Misato Okamura

513 total citations
31 papers, 350 citations indexed

About

Misato Okamura is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Neurology. According to data from OpenAlex, Misato Okamura has authored 31 papers receiving a total of 350 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Oncology, 9 papers in Pulmonary and Respiratory Medicine and 7 papers in Neurology. Recurrent topics in Misato Okamura's work include Cancer Immunotherapy and Biomarkers (11 papers), Intracerebral and Subarachnoid Hemorrhage Research (6 papers) and Nerve injury and regeneration (5 papers). Misato Okamura is often cited by papers focused on Cancer Immunotherapy and Biomarkers (11 papers), Intracerebral and Subarachnoid Hemorrhage Research (6 papers) and Nerve injury and regeneration (5 papers). Misato Okamura collaborates with scholars based in Japan, United Kingdom and United States. Misato Okamura's co-authors include Koichi Nakatani, Tadashi Mio, Kohei Fujita, Osamu Kanai, Yuki Yamamoto, Naohiro Uchida, Satoru Sawai, Masayuki Hashimoto, Hiroshi Maejima and Harutoshi Sakakima and has published in prestigious journals such as Journal of Clinical Oncology, Brain Research and Neuroscience.

In The Last Decade

Misato Okamura

28 papers receiving 348 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Misato Okamura Japan 10 258 165 51 38 35 31 350
Sheetal Shroff United States 5 199 0.8× 97 0.6× 18 0.4× 11 0.3× 46 1.3× 11 293
Kenji Otsuka Japan 12 141 0.5× 117 0.7× 36 0.7× 5 0.1× 93 2.7× 32 321
Yuehao Lin China 9 130 0.5× 51 0.3× 30 0.6× 6 0.2× 80 2.3× 11 328
Pramila Krishnamurthy United Kingdom 10 79 0.3× 45 0.3× 31 0.6× 15 0.4× 99 2.8× 32 502
Haiyang Chen China 11 118 0.5× 111 0.7× 36 0.7× 5 0.1× 192 5.5× 44 400
Liselot Valkenburg‐van Iersel Netherlands 8 122 0.5× 69 0.4× 15 0.3× 9 0.2× 62 1.8× 21 225
Sarah Theurer Germany 11 78 0.3× 27 0.2× 70 1.4× 9 0.2× 62 1.8× 46 317
Wenjuan Yu China 12 88 0.3× 147 0.9× 20 0.4× 3 0.1× 178 5.1× 40 314
J. Agustin Cruz United States 8 54 0.2× 27 0.2× 27 0.5× 17 0.4× 109 3.1× 10 336

Countries citing papers authored by Misato Okamura

Since Specialization
Citations

This map shows the geographic impact of Misato Okamura's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Misato Okamura with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Misato Okamura more than expected).

Fields of papers citing papers by Misato Okamura

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Misato Okamura. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Misato Okamura. The network helps show where Misato Okamura may publish in the future.

Co-authorship network of co-authors of Misato Okamura

This figure shows the co-authorship network connecting the top 25 collaborators of Misato Okamura. A scholar is included among the top collaborators of Misato Okamura based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Misato Okamura. Misato Okamura is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Kondo, Yuki, et al.. (2024). Potential effect of physical exercise on the downregulation of BDNF mRNA expression in rat hippocampus following intracerebral hemorrhage. Neuroscience Letters. 824. 137670–137670. 1 indexed citations
3.
Okamura, Misato, et al.. (2023). Pharmacological inhibition of histone deacetylases ameliorates cognitive impairment after intracerebral hemorrhage with epigenetic alteration in the hippocampus. Journal of Stroke and Cerebrovascular Diseases. 32(9). 107275–107275. 2 indexed citations
4.
5.
Fujita, Kohei, Misato Okamura, Yuki Yamamoto, et al.. (2022). Natural course of pulmonary hyalinizing granuloma over a decade. Respiratory Medicine Case Reports. 39. 101715–101715. 1 indexed citations
6.
Fujita, Kohei, Paul Elkington, Gil Redelman‐Sidi, et al.. (2022). Serial interferon-gamma release assay in lung cancer patients receiving immune checkpoint inhibitors: a prospective cohort study. Cancer Immunology Immunotherapy. 71(11). 2757–2764. 8 indexed citations
7.
Okamura, Misato, et al.. (2021). Combined treatment with exercise and α5GABAAR inhibitor promotes motor function recovery after intracerebral hemorrhage. Neuroscience Letters. 766. 136344–136344. 6 indexed citations
8.
Kanai, Osamu, Kohei Fujita, Misato Okamura, Koichi Nakatani, & Tadashi Mio. (2021). Afebrile tension pyopneumothorax due to anaerobic bacteria: Fistula or gas production?. Respiratory Medicine Case Reports. 32. 101372–101372. 3 indexed citations
9.
Okamura, Misato, et al.. (2021). In vivo local transcranial static magnetic field stimulation alters motor behavior in normal rats. Neuroscience Letters. 753. 135864–135864. 2 indexed citations
10.
11.
Fujita, Kohei, Misato Okamura, Yuki Yamamoto, et al.. (2021). Efficacy and safety of immune checkpoint inhibitors in patients with non‐small cell lung cancer aged 80 years or older. Cancer Reports. 4(6). 9 indexed citations
12.
Okamura, Misato, Kohei Fujita, Yuki Yamamoto, et al.. (2020). Single‐center analysis of antiresorptive agent‐related osteonecrosis of the jaw in lung cancer patients. Asia-Pacific Journal of Clinical Oncology. 16(6). 380–384. 2 indexed citations
13.
Fujita, Kohei, Misato Okamura, Yoshiaki Okuno, et al.. (2020). Pleural involvement of diffuse large B-cell lymphoma mimicking malignant pleural mesothelioma. Respiratory Medicine Case Reports. 31. 101206–101206.
14.
Okamura, Misato, et al.. (2020). Exercise Plus Pharmacological Neuromodulation of Synaptic Inhibition Enhance Motor Function Recovery After Ischemic Stroke. Neuroscience. 430. 12–24. 10 indexed citations
15.
Okamura, Misato, et al.. (2020). Low-Level Inhibition of GABAergic Synapses Enhances Gene Expressions Crucial for Neuronal Plasticity in the Hippocampus After Ischemic Stroke. Journal of Stroke and Cerebrovascular Diseases. 29(12). 105316–105316. 7 indexed citations
16.
Fujita, Kohei, Naohiro Uchida, Yuki Yamamoto, et al.. (2019). Retreatment With Anti-PD-L1 Antibody in Advanced Non-small Cell Lung Cancer Previously Treated With Anti-PD-1 Antibodies. Anticancer Research. 39(7). 3917–3921. 55 indexed citations
17.
Kanai, Osamu, et al.. (2018). Cutaneous lymphangitis carcinomatosa made cervicofacial oedema intractable in a patient with superior vena cava syndrome. BMJ Case Reports. 2018. bcr–2018. 2 indexed citations
18.
Uchida, Naohiro, Kohei Fujita, Misato Okamura, Koichi Nakatani, & Tadashi Mio. (2018). The clinical benefits of immune checkpoint inhibitor for thymic carcinomas ∼experience of single public hospital in Japan∼. Respiratory Medicine Case Reports. 26. 39–41. 7 indexed citations
19.
Fujita, Kohei, Naohiro Uchida, Osamu Kanai, et al.. (2018). Retreatment with pembrolizumab in advanced non-small cell lung cancer patients previously treated with nivolumab: emerging reports of 12 cases. Cancer Chemotherapy and Pharmacology. 81(6). 1105–1109. 73 indexed citations
20.
Nishii, Ryuichi, Tatsuya Higashi, Shinya Kagawa, et al.. (2013). Diagnostic usefulness of an amino acid tracer, α-[N-methyl-11C]-methylaminoisobutyric acid (11C-MeAIB), in the PET diagnosis of chest malignancies. Annals of Nuclear Medicine. 27(9). 808–821. 17 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Sheetal Shroff Breakdown of academic impact, for papers by Kenji Otsuka Breakdown of academic impact, for papers by Yuehao Lin Breakdown of academic impact, for papers by Pramila Krishnamurthy Breakdown of academic impact, for papers by Haiyang Chen Breakdown of academic impact, for papers by Liselot Valkenburg‐van Iersel Breakdown of academic impact, for papers by Sarah Theurer Breakdown of academic impact, for papers by Wenjuan Yu Breakdown of academic impact, for papers by J. Agustin Cruz
Rankless by CCL
2026